Details about the neuroanatomical projections from ORBl to PERI

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
91832 Orbital area lateral partPerirhinal area strongbiotinylated dextran amine (BDA)
a dense plexus of labeled axons and axonal varicosities in rostral PER, especially in the fundus and the dorsal bank of the rhinal sulcus, involving dorsal area 35 and ventral area 36 (Figs. 7B, 11D). Collator note: the terminal field is mostly in layer III, with some extension in layer V. See Fig. 7B, Swanson Atlas Levels 33-34.
Kondo H. & Witter M.P., 2014
91836 Orbital area lateral partPerirhinal area moderate/strongbiotinylated dextran amine (BDA)
[…] labeling extended farther rostrally in this case (Fig. 7A) compared with MO (Fig. 4) and ventral VO (Fig. 6) cases. Collator note: strong-moderate label in both PERI and ECT, rostralmost. Terminals are intermingled with fibers of passage, and are distributed in layers III and V. See Fig. 7A, Swanson Atlas Levels 31-32.
Kondo H. & Witter M.P., 2014
91837 Orbital area lateral partPerirhinal area lightbiotinylated dextran amine (BDA)
At more caudal levels, labeling in PER decreased in density (Fig. 7C) and was absent caudally in PER (Fig. 7D). Collator note: weak terminal field in layer III, at this level. See Fig. 7C, Swanson Atlas Levels 35-36.
Kondo H. & Witter M.P., 2014
91839 Orbital area lateral partPerirhinal area not presentbiotinylated dextran amine (BDA)
At more caudal levels, labeling in PER decreased in density (Fig. 7C) and was absent caudally in PER (Fig. 7D). Collator note: Swanson Atlas Levels 42-43.
Kondo H. & Witter M.P., 2014
91848 Orbital area lateral partPerirhinal area light/moderatebiotinylated dextran amine (BDA)
The injection produced labeled axons and terminals rostrally in PER, but labeling was weak (Figs. 8A,B, 11E) or absent in the middle and caudal portions of PER (Fig. 8C–E). Collator note: weak-moderate label at best in the rostral PERI. The label is mostly in layers II-III, with very few terminals in V. See Fig. 8A-B, Swanson Atlas Levels 30-32.
Kondo H. & Witter M.P., 2014
91849 Orbital area lateral partPerirhinal area not presentbiotinylated dextran amine (BDA)
The injection produced labeled axons and terminals rostrally in PER, but labeling was weak (Figs. 8A,B, 11E) or absent in the middle and caudal portions of PER (Fig. 8C–E). Collator note: no label in the caudal two thirds of the PERI. See Fig. 8C-E, Swanson Atlas Levels 35-43.
Kondo H. & Witter M.P., 2014
91863 Orbital area lateral partPerirhinal area moderate/strongbiotinylated dextran amine (BDA)
Collator note: weak-moderate field in the deep layers of the PERI, and moderate-strong in the dorsal part, extending into the ECT in this level. See Fig. 11F.
Kondo H. & Witter M.P., 2014
General description technique/protocol: In a representative case (case F-30), the BDA injection was centered in layers II–III of VLO in the middle of the orbital surface (Figs. 2, 3C, 7, Table 2). Collator note: small BDA injection in the ORBl, centrally, mapped here onto Swanson Atlas Levels 5-6.

Further details associated to record number 91839:
Position of injection: mid-rostro-caudal
Topological position of injection: is contained
Extension of injection outside: none
The injection was performed in: left hemisphere